Browse Category

NYSE:AB News 27 January 2026

AllianceBernstein stock jumps 7.5%; AB traders eye Fed week and Feb. 5 earnings

AllianceBernstein stock jumps 7.5%; AB traders eye Fed week and Feb. 5 earnings

AllianceBernstein units traded near $41.88 premarket Tuesday after jumping 7.49% Monday, with 1.63 million units changing hands. The firm’s assets under management rose to $867 billion in December, though net flows were slightly negative. No company statement has explained Monday’s surge. AllianceBernstein reports Q4 results before the market opens Feb. 5.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop